Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Regulator of nonsense transcripts 1 (UPF1) is a highly conserved ATP-dependent RNA helicase that serves as the central engine of the nonsense-mediated mRNA decay (NMD) pathway (UniProt P30801). NMD is a critical cellular quality control mechanism that identifies and degrades messenger RNAs (mRNAs) harboring premature termination codons (PTCs), preventing the synthesis of potentially deleterious truncated proteins. The activity of UPF1 is tightly regulated by a cycle of phosphorylation and dephosphorylation, primarily mediated by the kinase SMG1 and the phosphatase complex PP2A. In many genetic diseases, such as cystic fibrosis and Duchenne muscular dystrophy, NMD is considered a therapeutic target because it degrades mRNAs that could otherwise produce partially functional proteins if allowed to persist. In oncology, NMD inhibition is an emerging strategy to enhance the expression of tumor-specific neoantigens or to restore the expression of mutated tumor suppressor genes. Small molecules like Amlexanox and experimental inhibitors like NMDI-1 target this pathway to modulate RNA stability for clinical benefit.
Inhibition of the NMD machinery to prevent the degradation of mRNAs containing premature termination codons (PTCs), thereby stabilizing transcripts to allow for the translation of truncated or full-length proteins, or to increase neoantigen presentation in tumors.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Regulator of nonsense transcripts 1 (UPF1) (UPF1).